Cargando…
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
Clinical pharmacology is an integral discipline supporting the development, regulatory evaluation, and clinical use of drugs for the treatment of both common and rare diseases. Here, we evaluated the recommendations and information available from select clinical pharmacology studies in the therapeut...
Autores principales: | Hsieh, Julie, Sahre, Martina, Yang, Xinning, Madabushi, Rajanikanth, Ramamoorthy, Anuradha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652444/ https://www.ncbi.nlm.nih.gov/pubmed/36165094 http://dx.doi.org/10.1111/cts.13362 |
Ejemplares similares
-
Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010) -
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
por: Bai, Jane P. F., et al.
Publicado: (2021) -
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
por: Abulwerdi, Gelareh A., et al.
Publicado: (2023) -
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis
por: Michaeli, Thomas, et al.
Publicado: (2023) -
Do investors value the FDA orphan drug designation?
por: Miller, Kathleen L.
Publicado: (2017)